To Evaluate the Safety and Efficacy of RP902 Tablets

NCT07579884 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

360

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Cognitive Impairment (MCI)

Interventions

DRUG: RP902
DRUG: Placebo

Sponsor

Risen (Suzhou) Pharma Tech Co., Ltd.